Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Non-interventional, Multicenter Study Aimed at Collecting Prospective Data Related to Study Safety and Effectiveness in Real Clinical Practice in Patients With CD30+ Lymphoma (BRAVE Study)

NCT04837222 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04837222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04837222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Non-interventional, Multicenter Study Aimed at Collecting Prospective Data Related to Study Safety and Effectiveness in Real Clinical Practice in Patients With CD30+ Lymphoma (BRAVE Study)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
June 7, 2021
Completion date
June 26, 2026
Enrollment
1,000 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma